These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 793856)
1. [Drugs in tablets]. Borzunov EE Farm Zh; 1976; (4):17-21. PubMed ID: 793856 [No Abstract] [Full Text] [Related]
2. Drug formulation and biologic availability. Poole JW Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883 [No Abstract] [Full Text] [Related]
3. Formulations and dosages of oral drugs. Calesnick B Am Fam Physician; 1978 Sep; 18(3):160-2. PubMed ID: 685796 [No Abstract] [Full Text] [Related]
4. Solid oral dosage forms. Helliwell M; Taylor D Prof Nurse; 1993 Feb; 8(5):313-7. PubMed ID: 8451252 [TBL] [Abstract][Full Text] [Related]
5. [Absorption of the drug-contents of enteric-coated tablets]. Tikkanen R Nord Med; 1967 Nov; 78(47):1564-7. PubMed ID: 6075282 [No Abstract] [Full Text] [Related]
6. [Galenical possibilities and problems in protraction of drug effects (author's transl)]. Müller F Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277 [TBL] [Abstract][Full Text] [Related]
7. [Effect of the production process on the quality of drugs]. Murav'ev IO Farm Zh; 1976; (2):20-7. PubMed ID: 1269692 [No Abstract] [Full Text] [Related]
8. Importance of pharmaceutical formulation for drug absorption. Sjögren J Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():68-80. PubMed ID: 5316412 [No Abstract] [Full Text] [Related]
9. [Ways to prolong the action of drugs in opthalmic drug forms]. Tishina IF Farmatsiia; 1974; (6):62-7. PubMed ID: 4618814 [No Abstract] [Full Text] [Related]
10. [The consequence of the preparation factors for the effect of the drug]. Johnsgård M; Pedersen AO Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086 [No Abstract] [Full Text] [Related]
11. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations. Tajiri S; Kanamaru T; Kamada M; Konno T; Nakagami H Int J Pharm; 2010 Jan; 383(1-2):99-105. PubMed ID: 19747964 [TBL] [Abstract][Full Text] [Related]
13. Dissolution of drugs from solid dosage forms. I. General aspects. Arayne MS; Sultana N J Pak Med Assoc; 1979 Sep; 29(9):193-200. PubMed ID: 117153 [No Abstract] [Full Text] [Related]
14. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies. Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183 [TBL] [Abstract][Full Text] [Related]
15. Drug delivery systems. Polack AE; Roberts MS Med J Aust; 1986 Mar; 144(6):311-4. PubMed ID: 3713622 [No Abstract] [Full Text] [Related]
16. Therapeutic inequivalence of pharmaceutical alternates. Levy RA Am Pharm; 1985 Apr; NS25(4):28-39. PubMed ID: 3893084 [No Abstract] [Full Text] [Related]
17. [Drugs that should not be triturated]. Fernández Contreras V Rev Enferm; 1992; 15(167-168):22-4. PubMed ID: 1641559 [No Abstract] [Full Text] [Related]
18. A flexible technology for modified release of drugs: multi layered tablets. Abdul S; Poddar SS J Control Release; 2004 Jul; 97(3):393-405. PubMed ID: 15212872 [TBL] [Abstract][Full Text] [Related]
19. Modified release from hydroxypropyl methylcellulose compression-coated tablets. Rujivipat S; Bodmeier R Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759 [TBL] [Abstract][Full Text] [Related]
20. [Principal results of scientific studies in biopharmaceutics]. Tentsova AI Farmatsiia; 1977; 26(4):1-4. PubMed ID: 902784 [No Abstract] [Full Text] [Related] [Next] [New Search]